WeVote
Log In

Bill

Bill

S 4067

Requires health insurance carriers to reimburse health care providers for vaccines at rate no less than CDC cost per dose rate.

2024-2025 Regular Session Introduced by Vin Gopal

New Jersey bill requires insurers to reimburse vaccine providers at CDC cost-per-dose rates, ensuring provider reimbursement floors for vaccinations.

Introduced in the Senate, Referred to Senate Commerce Committee
#healthinsur
0
WeVote Research Nonpartisan
Bill Summary · S 4067

Legislative bill overview

S 4067 mandates that health insurance carriers reimburse healthcare providers for vaccines at rates not lower than the CDC's established cost-per-dose rate. The bill specifically targets reimbursement rates for vaccine administration and procurement, tying them to federal CDC pricing benchmarks rather than allowing carriers to negotiate lower rates independently.

Why is this important

Vaccine reimbursement rates directly affect provider willingness to stock and administer vaccines, which can impact public health immunization rates. If reimbursement falls below actual costs, providers may limit vaccine availability or deprioritize vaccination services, potentially reducing vaccination coverage in communities. This bill attempts to ensure financial viability of vaccination services across healthcare settings.

Potential points of contention

  • Cost impact on insurers: Health insurers argue lower negotiated rates control premium costs for consumers; this mandate could increase their expenses and potentially raise insurance premiums
  • Market competition concerns: Policymakers may worry that tying reimbursement to CDC rates removes price negotiation flexibility and could reduce market competition among suppliers
  • Definition ambiguity: The bill may need clarification on which specific CDC rates apply (different vaccines, different provider types) and whether this includes administration fees or only vaccine costs
  • Provider equity: Varying CDC rates across different vaccine types could create financial incentives for certain vaccines over others, potentially distorting clinical decision-making

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.